Borsi, E; Perrone, G; Terragna, C; Martello, M; Mancini, M; Leo, E; Zamagni, E; Tacchetti, P; Brioli, A; Pantani, L; Zannetti, B; Martinelli, G; Cavo, M, SIRT regulates the molecular interaction between c-MYC and HIF-1 alpha in multiple myeloma, in: CANCER RESEARCH, 2013, pp. 3415 - 3415 (atti di: 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, APR 06-10, 2013) [Abstract]
Terragna, C; Martello, M; Martinelli, G; Durante, S; Pantani, L; Zamagni, E; Tacchetti, P; Brioli, A; Perrone, G; Zannetti, Ba; Borsi, E; Biasco, G; Baccarani, M; Cavo, M., Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5, in: Suppl. 1, Chicago, «CANCER RESEARCH», 2012, 72, pp. 1873 - 1873 (atti di: AACR 2012 Annual Meeting, Chicago, 30 March - 04 April 2012) [Abstract]
G Perrone; E Borsi; C Terragna; M Martello; M Mancini; M Aluigi; MA Santucci; G Martinelli; M Baccarani; M Cavo, HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA, in: s1, «HAEMATOLOGICA», 2012, 97, pp. 105 - 105 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [Abstract]
Terragna C; Martello M; Pantani L; Patriarca F; Zamagni E; Galli M; Tacchetti P; Petrucci MT; Crippa C; Bringhen S; Brioli A; Offidani M; Perrone G; Zannetti BA; Borsi E; Testoni N; Marzocchi G; Baccarani M; Martinelli G; Cavo M., High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53, in: s1, «HAEMATOLOGICA», 2012, 97, pp. 240 - 240 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [Abstract]
Terragna, C ; Remondini, D; Durante, S; Martello, M; Patriarca, F; Levi, A; Pantani, L; Donnarumma, D ; Crippa, C; Bringhen, S; Rambaldi, A ; Offidani, M; Corradini, P; Narni, F; Fioritoni, G; Zaccaria, A; Baldini, L; Caravita, T; La Nasa, G; Cortelazzo, S; Martinelli, G; Baccarani, M; Cavo, M, A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM), in: Blood, 2011, pp. 366 - 366 (atti di: 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 10-13, 2011) [Abstract]
PERRONE G; BORSI E; TERRAGNA C; DURANTE S; MARTELLO M; ALUIGI M; MANCINI M; ZAMAGNI E; TACCHETTI P; BRIOLI A; PANTANI L; ZANNETTI BA; MARTINELLI G; SANTUCCI MA; BACCARANI M; CAVO M, HIF 1 Alpha: A Suitable Target for Multiple Myeloma, in: Blood, «BLOOD», 2011, 118, pp. 2901 - 2901 (atti di: 2011 ASH Annual Meeting, San Diego, CA, 9 – 12 December) [Abstract]
TERRAGNA C; MARTELLO M; DURANTE S; PANTANI L; ZAMAGNI E; TACCHETTI P; BRIOLI A; PERRONE G; ZANNETTI BA; BORSI E; BACCARANI M; MARTINELLI G; CAVO M, High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53, in: Blood, «BLOOD», 2011, 118, pp. 3935 - 3935 (atti di: 2011 ASH Annual Meeting, San Diego, CA, 9 – 12 December) [Abstract]
